Formamide

Formamide

SCHEMBL20768110

Cc1c(N2CCOCC2)oc2cccc(C)c2c1=O.NC=O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 5/20 0.41
ERBB2 P04626 1/20 0.38
RET P07949 1/20 0.38
PDGFRB P09619 1/20 0.38
KCNA3 P22001 1/20 0.38
P2RY12 Q9H244 1/20 0.38
LMNA P02545 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
NSD2 O96028 1/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CB P42338 1/20 0.37
PIK3CG P48736 1/20 0.37
MAPT P10636 3/20 0.36
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 2/20 0.36
POLB P06746 2/20 0.36
ACE P12821 1/20 0.36
ECE1 P42892 1/20 0.36
CNR2 P34972 1/20 0.36
MEN1 O00255 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28095508 0.94 PRKDC (0.45) PRKDCERBB2RETPDGFRBKCNA3
Formamide SCHEMBL29160439 0.84 PIK3CA (0.37) PRKDCPIK3CDPIK3CBPIK3CG
Formamide SCHEMBL29160413 0.78 P2RY12 (0.39) PRKDCKCNA3P2RY12LMNAL3MBTL1
SCHEMBL31035358 0.73 P2RY12 (0.40) PRKDCKCNA3P2RY12LMNAL3MBTL1
SCHEMBL28095893 0.72 P2RY12 (0.44) PRKDCKCNA3P2RY12PIK3CDPIK3CG
SCHEMBL7329373 0.69 P2RY12 (0.54) PRKDCKCNA3P2RY12ALDH1A1KDM4E
SCHEMBL31035311 0.69 PRKDC (0.61) PRKDCKCNA3P2RY12L3MBTL1ALDH1A1
SCHEMBL31035103 0.68 NUDT1 (0.37) PRKDCKCNA3P2RY12L3MBTL1MAPT
SCHEMBL7319096 0.68 PRKDC (0.54) PRKDCRETLMNAPIK3CDPIK3CB
SCHEMBL7315291 0.67 PRKDC (0.59) PRKDCP2RY12LMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190070166-A1 Optimized Method for Treating and Curing Arthritis, Diabetes, Multiple Sclerosis and Other Autoimmune Disease POSTREL RICHARD (US) 2019-03-07 US claimed
CN-117615763-A Phosphoinositide 3 kinase beta inhibitor, composition and preparation method thereof 健道生物医药有限公司 2024-02-27 CN disclosed
CN-116096710-A 4-oxo-3, 4-dihydroquinazolinone compounds for the treatment of BRAF related diseases and disorders 阿雷生物药品公司 2023-05-09 CN disclosed
CN-114026073-A Quinazolin-4-one derivatives for the treatment of BRAF related diseases and disorders ARRAY生物制药公司 2022-02-08 CN disclosed